From Nasdaq: 2024-11-20 14:25:00

Hims & Hers Health (HIMS) saw significant growth with a multi-specialty telehealth platform offering access to treatments like ED pills. Amazon’s (AMZN) One Medical telehealth service entering the market caused HIMS stock to drop, now trying to recover. Technical analysis by Bartosiak examines moving averages, support/resistance levels, chart patterns, and volume for informed investment decisions. Zacks Research highlights a financial firm stock with potential to double, based on innovative solutions and growing customer base. The stock has the potential for significant gains, surpassing previous Zacks picks like Nano-X Imaging.



Read more at Nasdaq: Will Amazon Bury Hims Stock or Should You Buy the Dip?